These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 6528562)

  • 1. [Diurnal fluctuations in hormone secretion in hypophyseal adenomas].
    Epshteĭn EV; Biriukova LN; Oleĭnik VA
    Vrach Delo; 1984 Nov; (11):63-5. PubMed ID: 6528562
    [No Abstract]   [Full Text] [Related]  

  • 2. [A clinico-experimental study of the functional morphology of hypophyseal adenomas].
    Korsić M; Zarković K; Zarković N; Plavsić V; Paladino J; Skorić T; Aganović I; Kozić-Rukavina B; Giljević Z; Perković Z; Breskovac L; Melada A; Pirker N
    Lijec Vjesn; 1998 Sep; 120(9):262-73. PubMed ID: 10099666
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy in acromegaly].
    Góth M; Korbonits M
    Orv Hetil; 2004 Apr; 145(16):867-71. PubMed ID: 15156692
    [No Abstract]   [Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
    Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of immunohistochemical methods in the diagnosis and prognosis of pituitary hormone-producing adenomas].
    Montero C
    Med Clin (Barc); 1986 Dec; 87(19):802-4. PubMed ID: 3821233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Functional morphology and prognosis of hormonally-active pituitary adenomas].
    Iushkov PV; Gracheva IA; Marova EI
    Arkh Patol; 2001; 63(5):50-7. PubMed ID: 11765417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin and pituitary tumors.
    Silvestrini F; Liuzzi A; Chiodini PG
    Curr Top Exp Endocrinol; 1978; 3():131-72. PubMed ID: 26521
    [No Abstract]   [Full Text] [Related]  

  • 8. Some changes of receptor and postreceptor signal transduction regulated by somatostatin in pituitary hGH-secreting adenomas.
    Deng J; Shi Y; Yin J
    Chin Med J (Engl); 1997 Sep; 110(9):678-81. PubMed ID: 9642323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pathomorphology of hypophyseal adenomas].
    Kasumova SIu; Akshulakov SK
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (5):10-2. PubMed ID: 2596222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene.
    Yamada M; Monden T; Satoh T; Satoh N; Murakami M; Iriuchijima T; Kakegawa T; Mori M
    Biochem Biophys Res Commun; 1993 Sep; 195(2):737-45. PubMed ID: 8396925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [TSH-secreting pituitary adenoma: 16 years follow-up].
    Koch CA; Skarulis MC; Patronas NJ; Sarlis NJ
    Med Klin (Munich); 2000 Jan; 95(1):49-50. PubMed ID: 10668345
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of growth hormone-secreting pituitary adenomas--early diagnosis leads to successful treatment.
    King WA
    West J Med; 1993 Jan; 158(1):68. PubMed ID: 8470392
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of rosiglitazone--peroxisome proliferators-activated receptor gamma (PPARgamma) agonist on cell viability of human pituitary adenomas in vitro.
    Winczyk K; Kunert-Radek J; Gruszka A; Radek M; Ławnicka H; Pawlikowski M
    Neuro Endocrinol Lett; 2009 Mar; 30(1):107-10. PubMed ID: 19300395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functioning and non-functioning pituitary adenomas in 173 adult and elderly patients.
    Gasco V; Gaia D; Tassone F; Razzore P; Ciccarelli E; Grottoli S
    J Endocrinol Invest; 2002; 25(10 Suppl):57-8. PubMed ID: 12508919
    [No Abstract]   [Full Text] [Related]  

  • 15. Fine structural features of secretion in adenomas of human pituitary gland.
    Ryder DR; Horvath E; Kovacs K
    Arch Pathol Lab Med; 1980 Oct; 104(10):518-22. PubMed ID: 6774693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructure of the human pituitary adenoma.
    Howng SL; Wang JR
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Oct; 3(10):661-7. PubMed ID: 3329234
    [No Abstract]   [Full Text] [Related]  

  • 17. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone.
    Sen O; Ertorer ME; Aydin MV; Erdogan B; Altinors N; Zorludemir S; Guvener N
    J Clin Neurosci; 2005 Apr; 12(3):318-20. PubMed ID: 15851094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid-stimulating hormone hypophyseal adenoma. A case report].
    Gannage MH; Maacaron C; Okais N; Halaby G
    J Med Liban; 1997; 45(2):97-101. PubMed ID: 9289506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
    Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired growth hormone secretion in patients operated for pituitary adenomas.
    Hoeck HC; Bang F; Laurberg P
    Growth Regul; 1994 Jun; 4(2):63-7. PubMed ID: 7950904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.